News

Cancers and precancers of the oral mucosa are notoriously challenging to treat and, according to one expert, a heightened vigilance spanning different specialties remains key in reducing the morbidity and mortality in patients.

Dermatologists are best positioned to treat and educate patients whose tattoos, piercings and other body adornments are causing problems, an expert says.

How do we age? That was the weighty question to kick off a presentation by Barbara A. Gilchrest, M.D., Boston University School of Medicine, who presented at MauiDerm earlier this year.

Except in limited instances, an expert says, topical therapies for medical management of nonmelanoma skin cancers (NMSCs) work best as adjuncts to surgery.

In preparing and organizing presentations, an expert says, keeping the content fresh and tightly edited helps both audience and speaker.

Not all office politics are inherently bad - the key is how individuals in a group work together to meet common goals, according to an expert.

Which products do you use and in which plane do you inject when rejuvenating the temple? A panel of experts in dermatology and plastic surgery identify their preferences for devices and techniques for temple revolumization.

No cryptic cartel, the American Medical Association (AMA)/Specialty Society Relative Value Scale Update Committee (RUC) is an indispensable piece of the healthcare payment puzzle that beats less logical options that have been proposed, dermatologists say.

I have recently been thinking about the many changes in the practice of medicine, both big and small, that have occurred during the last few decades and I’ve come up with quite a list.

A new hair restoration method may give previously unsuitable candidates the chance to regrow hair, according to results of a recent study.

Dermatologists need to keep vaccinations in mind when treating patients with psoriasis and psoriatic arthritis, according to the National Psoriasis Foundation (NPF).

Some misconceptions have sprung up about sunscreen SPF values. Curtis Cole, Ph.D., sees a need to dispel some myths, and a need for for dermatologists to do a better job of educating their patients about sun protection.

The FDA has approved the cosmetic filler Juvéderm Voluma XC (Allergan), a hyaluronic acid filler. It is the first and only filler to be approved for the temporary correction of age-related volume loss in adult patients ages 21 and older.

Lack of patient adherence to prescribed therapies remains a central issue in dermatology and, according to one expert, a multifaceted strategy can improve compliance, leading to improved treatment outcomes.

An attempt to positively affect stage 2 melanomas with a certain vaccine didn’t prove beneficial in a recent study by the European Organization for Research and Treatment of Cancer (EORTC).

The Biomedical Advanced Research and Development Authority (BARDA) has awarded a contract to Novan Therapeutics to develop a topical nitric-oxide-based burn therapy.

New research suggests that the body’s internal clock and its circadian rhythms adjust the modulation of skin stem cells based on the time of day - and that disruption to this cycle can cause tissue aging and lead to predisposition to skin cancer.

Secukinumab (AIN457), an interleukin-17A (IL-17A) inhibitor, was more effective in treating moderate-to-severe plaque psoriasis than the anti-tumor necrosis factor etanercept and current standard of care, according to a head-to-head phase 3 study.

Updated classification criteria for scleroderma should allow for earlier identification and treatment of the autoimmune disease.

The topical anti-fungal agent ciclopirox causes HIV-infected cells to commit suicide by jamming up the cells’ powerhouse, the mitochondria, according to a recent study.

Clinical trials commenced last week for what may be the first protein therapeutic for X-linked hypohidrotic ectodermal dysplasia (XLHED).

Adalimumab (Humira, AbbVie) is demonstrating effectiveness in early trials for the treatment of hidradenitis suppurativa, a condition that as of yet has no approved treatment.

The Food and Drug Administration has granted 510(k) clearance to Nucletron for Esteya, an electronic brachytherapy system for high-precision skin cancer treatment.

Cimzia (certolizumab pegol, UCB) has been approved by the Food and Drug Administration for the treatment of psoriatic arthritis in adult patients.

Long-term analysis of patients with advanced melanoma taking ipilimumab demonstrated survival rates of up to 10 years, according to recent research.

Strathspey Crown Holdings has acquired Evolus, which will allow Strathspey Crown’s wholly-owned subsidiary, Alphaeon Corporation, the exclusive license to market the botulinum toxin type A product Evosyal.

Among the most troublesome stage 2 requirements of the Medicare and Medicaid EHR Incentive Programs is the requirement that 5 percent of patients use the Internet to communicate with practices, an expert says.

New genetic testing methods may not only help identify the potential risk for individuals to develop certain diseases but may also open the door for more targeted therapies and management strategies, which could be of particular benefit in higher risk patient populations.

Vitamin D has been in and out of favor with physicians and their patients over the years. Even today, the controversies over the embattled vitamin still continue regarding its safe and beneficial daily allowance. According to the recent research, however, and guidelines from the Institute of Medicine (IOM), the majority of Americans are taking enough vitamin D.

In the European Union (EU), a simple approval process for hyaluronic acid (HA) products has yielded a broader array of offerings than what’s available in the United States, an expert says. Easier EU approvals also have given HA a virtual lock on the European filler market, he adds.